Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial

  1. González-Martín, A.
  2. Rubio, M.J.
  3. Heitz, F.
  4. Depont Christensen, R.
  5. Colombo, N.
  6. Van Gorp, T.
  7. Romeo, M.
  8. Ray-Coquard, I.
  9. Gaba, L.
  10. Leary, A.
  11. De Sande, L.M.
  12. Lebreton, C.
  13. Redondo, A.
  14. Fabbro, M.
  15. Barretina Ginesta, M.-P.
  16. Follana, P.
  17. Pérez-Fidalgo, J.A.
  18. Rodrigues, M.
  19. Santaballa, A.
  20. Sabatier, R.
  21. Bermejo-Pérez, M.J.
  22. Lotz, J.-P.
  23. Pardo, B.
  24. Marquina, G.
  25. Sánchez-Lorenzo, L.
  26. Quindós, M.
  27. Estévez-García, P.
  28. Guerra Alía, E.
  29. Manso, L.
  30. Casado, V.
  31. Kommoss, S.
  32. Tognon, G.
  33. Henry, S.
  34. Bruchim, I.
  35. Oaknin, A.
  36. Selle, F.
  37. Show all authors +
Journal:
Journal of Clinical Oncology

ISSN: 1527-7755 0732-183X

Year of publication: 2024

Volume: 42

Issue: 36

Pages: 4294-4304

Type: Article

DOI: 10.1200/JCO.24.00668 GOOGLE SCHOLAR

Sustainable development goals